PHARMA-SKAN ApS: Financial statements 2022
CVR: 16275247
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
PHARMA-SKAN ApS (CVR 16275247) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 14,799,792 and a net result of DKK 10,877,228 compared with DKK 9,069,004 the year before. That is an increase of 19.2% compared with the year before. Equity in the 2022 report amounted to DKK 18,881,200. The solvency ratio was 80.3%. The company had 13 employees in the financial year.
- Gross Profit
- DKK 14,799,792
- Profit/Loss
- DKK 10,877,228
- Equity
- DKK 18,881,200
- Total Assets
- DKK 23,501,325
- Employees
- 13
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 14.8 mio. | 10.9 mio. | 18.9 mio. | 13 |
| 2021 | - | 12.4 mio. | 9.1 mio. | 17 mio. | 13 |
| 2020 | - | 12.6 mio. | 9.3 mio. | 17.9 mio. | 14 |
| 2019 | - | 9.9 mio. | 7.2 mio. | 14.7 mio. | 12 |
| 2018 | - | 10.1 mio. | 7.4 mio. | 13.5 mio. | 11 |
Official annual report
Keep an eye on PHARMA-SKAN ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
PHARMA-SKAN ApS has published its annual report for 2021. Gross profit came to DKK 12,419,937, and the net result was DKK 9,069,004.
About PHARMA-SKAN ApS
PHARMA-SKAN ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ApS KBUS 38 NR. 2587. The management consists of Line Wulff and Ib Gunnar Christensen. The board consists of Jan Dam (chair), Kent Ernst Hansen, Lars Enghave Minor and Line Wulff. The company is owned by BESULA ApS. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK 12,339,941 and a net result of DKK 7,875,190 compared with DKK 11,288,304 the year before. Equity in the 2025 report amounted to DKK 8,543,005.